We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current SNY market cap is 150.08B. The company's latest EPS is EUR 2.2009 and P/E is 49.81.
| Quarter End | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 9.97B | 11.96B | 10.46B | 10.75B | 13.44B |
| Operating Income | 1.86B | 3.21B | 1.45B | 1.6B | 3.64B |
| Net Income | 1.44B | 2.53B | 1.13B | 1.11B | 2.82B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 36.04B | 37.76B | 43B | 43.07B | 46.11B |
| Operating Income | 6.42B | 7.71B | 10B | 7.19B | 7.02B |
| Net Income | 12.29B | 6.22B | 8.37B | 5.4B | 5.56B |
| Quarter End | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 125.35B | 0 | 0 | 129.76B | 0 |
| Total Liabilities | 52.41B | 0 | 0 | 56.76B | 0 |
| Total Equity | 72.95B | 0 | 0 | 73B | 0 |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 114.41B | 120.24B | 126.72B | 126.46B | 132.8B |
| Total Liabilities | 51.16B | 51.21B | 51.57B | 52.11B | 54.94B |
| Total Equity | 63.25B | 69.03B | 75.15B | 74.35B | 77.86B |
| Quarter End | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 3.56B | N/A | N/A | 1.42B | N/A |
| Investing | -3.07B | N/A | N/A | -3.41B | N/A |
| Financing | -5.21B | N/A | N/A | 89M | N/A |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 7.42B | 10.52B | 10.53B | 10.26B | 9.08B |
| Investing | 3.62B | -7.3B | -2.08B | -6.2B | -4.41B |
| Financing | -6.49B | -7.06B | -5.82B | -8.05B | -5.76B |
| Market Cap | 150.08B |
| Price to Earnings Ratio | 49.81 |
| Price to Sales Ratio | 6.01 |
| Price to Cash Ratio | 37.22 |
| Price to Book Ratio | 3.56 |
| Dividend Yield | 6.63% |
| Shares Outstanding | 2.53B |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.95 (1.59%) |
| Company Name | Sanofi |
| Address |
46, avenue de la grande armee paris, paris 75017 |
| Website | https://www.sanofi.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
